Skip to content
OpenCapital
Get started

Dare Bioscience, Inc. DARE Q1 2026 earnings

Reported May 14, 2026 · After market close

Revenue$152.5KBeat by $125.5K
EPS-$0.20Beat by $0.13
Revenue estimate$27.0K
EPS estimate-$0.33

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$1.7K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$152.5KBeat by $125.5K
Q4 2025$1.0MBeat by $272.2KQ3 2025$2.3KMiss by $762.7KQ2 2025-$21.2KMiss by $168.4KQ1 2025$25.4KMiss by $574.6KQ4 2024-$63.6KMiss by $1.1M

Diluted EPS

Q1 2026-$0.20Beat by $0.13
Q4 2025-$0.02Beat by $0.22Q3 2025-$0.28Beat by $0.05Q2 2025-$0.45Beat by $0.10Q1 2025-$0.50Beat by $0.13Q4 2024-$0.64Beat by $0.02

Ask the moment Dare Bioscience, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dare Bioscience, Inc. report Q1 2026 earnings?
Dare Bioscience, Inc. (DARE) reported Q1 2026 earnings on May 14, 2026 after market close.
What were Dare Bioscience, Inc.'s Q1 2026 revenue and EPS?
Dare Bioscience, Inc. reported revenue of $152.5K and eps of $-0.20 for Q1 2026.
Did Dare Bioscience, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $27.0K by $125.5K. EPS beat the consensus estimate of $-0.33 by $0.13.
How did Dare Bioscience, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 499.6% from $25.4K a year earlier and eps grew 60.0% from $-0.50.
Where can I find Dare Bioscience, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001401914-26-000025) and the 10-Q periodic report (0001401914-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.